Quarterly report pursuant to Section 13 or 15(d)

License Agreements and Clinical Research Support Agreements (Details Textual)

v3.7.0.1
License Agreements and Clinical Research Support Agreements (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jul. 03, 2017
May 31, 2017
Apr. 25, 2017
Feb. 28, 2017
Feb. 17, 2017
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Dec. 31, 2016
Research And Development Expense, Sponsored Research Payment         $ 2,000,000          
Research and Development Expense           $ 500,000 $ 500,000 $ 1,000,000 $ 1,000,000  
Common Stock, Shares, Outstanding           25,221,889   25,221,889   15,165,244
Psca Technology License [Member]                    
Payment Of Upfront Fees   $ 300,000                
Revenue Recognition Milestone Method Payments Due   14,900,000                
Maintenance Costs   50,000                
Cs Technology License [Member]                    
Payment Of Upfront Fees   600,000                
Revenue Recognition Milestone Method Payments Due   14,900,000                
Maintenance Costs   $ 50,000                
Stephen Forman [Member]                    
Annual Consulting Fees                   $ 60,000
Christine Brown [Member]                    
Annual Consulting Fees                   $ 60,000
University of California [Member] | UCLA License [Member]                    
Payment Of Upfront Fees     $ 200,000              
Other Commitment, Due in Next Twelve Months     15,000              
Other Commitment, Due in Third Year     25,000              
Other Commitment, Due in Second Year     15,000              
Other Commitment, Due in Fifth Year     50,000              
Other Commitment, Due in Fourth Year     $ 25,000              
City Of Hope [Member]                    
Revenue Recognition Milestone Method Payments Due         125,000          
Stock Issued During Period, Shares, Purchase of Assets               293,588    
Payments for Other Fees         125,000          
City Of Hope [Member] | AR CD123 License [Member]                    
Payment Of Upfront Fees       $ 19,450            
Revenue Recognition Milestone Method Payments Due         14,500,000          
Research And Development Expense, Sponsored Research Payment       231,300            
Research and Development Expense           $ 575,000        
Licencing Arrangements, Additional Costs Incurred       97,490            
Maintenance Costs       25,000            
City Of Hope [Member] | IL License [Member]                    
Payment Of Upfront Fees       9,238            
Revenue Recognition Milestone Method Payments Due         $ 14,500,000          
Research And Development Expense, Sponsored Research Payment       199,500            
Licencing Arrangements, Additional Costs Incurred       136,300            
Maintenance Costs       25,000            
City Of Hope [Member] | Her2 Technology License [Member]                    
Payment Of Upfront Fees $ 600,000                  
Revenue Recognition Milestone Method Payments Due 14,900,000                  
Maintenance Costs $ 50,000                  
City Of Hope [Member] | Spacer License [Member]                    
Maintenance Costs       $ 10,000            
City Of Hope [Member] | IL 13 CRA [Member]                    
Research and Development Expense               $ 1,000,000 $ 1,000,000  
Common Class A [Member]                    
Stock Issued During Period, Shares, Purchase of Assets               0    
Common Stock, Shares, Outstanding           1,000,000   1,000,000   1,000,000
Noncontrolling Interest, Ownership Percentage by Parent           5.00%   5.00%